The preliminary findings of the NBTS three-centre study showed that anti-HCV positivity indicated that a patient was suffering from non-A non-B Hepatitis, and that the test was detecting a viral marker associated with NANBH. The findings also included that, in general, 70-80% of patients suffering from treated (or severe) haemophilia were anti-HCV positive.